Nervous System Neoplasms: Clinical Trials

7 trials for Nervous System Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 suspended. 7 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Suspended 7
Phase 14Suspended 4

Follow Nervous System Neoplasms: new trials by email Literature Review of Nervous System Neoplasms trials Research Report on Nervous System Neoplasms

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CA-4948 in Combination With Pembrolizumab and Stereotactic Radiosurgery to Improve Treatment of Melanoma Brain Metastases
Emavusertib, Pembrolizumab, Stereotactic Radiosurgery - Metastatic Malignant Neoplasm in the Brain, Metastatic Melanoma
Phase 1 / Phase 2SuspendedMayo Clinic232026-11-302026-10-20
PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma
PEP-CMV vaccine, Tetanus booster, Nivolumab - Diffuse Midline Glioma, Diffuse Midline High-grade Glioma
Phase 1 / Phase 2SuspendedWashington University School of Medicine682026-11-302026-10-30
Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
NaviFUS System, Lumason, Bevacizumab - Glioblastoma Multiforme, Glioblastoma
Phase 1 / Phase 2SuspendedNaviFUS Corporation102024-10-222026-09-09
Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
Azeliragon, Stereotactic radiosurgery, Corticosteroid - Cancer, Metastasis
Phase 1 / Phase 2SuspendedBaptist Health South Florida462023-11-172026-06-16
A Phase 2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPG
SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS) - Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma
Phase 2SuspendedSonALAsense, Inc.152022-08-122024-09-19
A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)
Antineoplaston therapy (Atengenal + Astugenal) - Diffuse, Intrinsic Pontine Glioma
Phase 2SuspendedBurzynski Research Institute12016-04-132025-09-16
Biological Therapy in Treating Patients With Primary or Advanced Glioma
aldesleukin, lymphokine-activated killer cells - Brain and Central Nervous System Tumors
Phase 2SuspendedWeill Medical College of Cornell University1997-07-012009-02-09

Narrower conditions

Brain Neoplasms (4)  ·  Diffuse Intrinsic Pontine Glioma (3)  ·  Glioblastoma (2)  ·  Glioma (2)  ·  Neoplasms (2)  ·  Astrocytoma (1)  ·  Central Nervous System Neoplasms (1)  ·  Ependymoma (1)  ·  Gliosarcoma (1)  ·  Medulloblastoma (1)  ·  Melanoma (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Recurrence (1)

Broader conditions

Brain Diseases (7)  ·  Central Nervous System Diseases (7)  ·  Neoplasms by Site (7)  ·  Nervous System Diseases (7)  ·  Central Nervous System Neoplasms (6)  ·  Neoplasms by Histologic Type (6)  ·  Neoplasms, Germ Cell and Embryonal (6)  ·  Neuroectodermal Tumors (6)  ·  Neoplasms (5)  ·  Neoplasms, Glandular and Epithelial (5)  ·  Neoplasms, Nerve Tissue (5)  ·  Neoplasms, Neuroepithelial (5)  ·  Brain Neoplasms (3)  ·  Brain Stem Neoplasms (3)

Interventions

Radiosurgery (2)  ·  Adrenal Cortex Hormones (1)  ·  Bevacizumab (1)  ·  Biopsy (1)  ·  CA-4948 (1)  ·  Dexamethasone (1)  ·  Immunoglobulin G (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Methylprednisolone (1)  ·  Nivolumab (1)  ·  Specimen Handling (1)  ·  Temozolomide (1)  ·  aldesleukin (1)  ·  antineoplaston A10 (1)  ·  antineoplaston AS 2-1 (1)

Sponsors

Baptist Health South Florida (1)  ·  Burzynski Research Institute (1)  ·  Mayo Clinic (1)  ·  NaviFUS Corporation (1)  ·  SonALAsense, Inc. (1)  ·  Washington University School of Medicine (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (7)

Top investigators

Bently Doonan, MD, MS (1)  ·  Corina Andresen, MD (1)  ·  Eric M Thompson, M.D. (1)  ·  Minesh Mehta, M.D. (1)  ·  Roberta L. Hayes, PhD (1)  ·  Stanislaw R. Burzynski, MD, PhD (1)

Results publications

PMID 8625188

NIH funding

R01CA296813 (1), R44CA261516 (1)